Skip to content
Global sound
The CheckRare Brief

The CheckRare Brief

FDA Approves New Narcolepsy Treatment

· 7 min · Season 1 Episode 2

Show notes

On this week’s episode of The CheckRare Brief, we discuss FDA’s approval of Orzeyful (oveporexton) to treat patients with narcolepsy type 1, CAMP4’s first-in-human clinical trial for patients with SYNGAP1-related disorders, and BioMarin’s termination for their ENPP1 deficiency program following mixed results from their phase 3 clinical trial.

The US Food and Drug Administration (FDA) approved Takeda’s Orzeyful (oveporexton) for narcolepsy type 1 on August 5, 2026. The approval came nearly two months ahead of its September 30th PDUFA date. Oveporexton is an orexin receptor 2 agonist designed…

Website: spreaker.com

Live, last hour: 7,197 songs on 2,753 stations in 119 countries

Discover the world through radio

More ways to discover (7)

Heard something good? Save it, or open it straight away in Spotify.

★ Artist of the week The fastest riser on the radio this week
Your song here? From € 9 per week →
Radio 538 luisteren - Live!Popular right now